Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS2W
Performance in the last:
Follow this Portfolio
1D 0.8 %
1W 3.7 %
2W 1.7 %
1M 0.8 %
3M 4.8 %
6M -39.2 %
9M -29.9 %
1Y -34.8 %
Alpha
-47.8%
Beta
0.53
sharpe-R
-0.69
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:52
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -49.92%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
NVCR NovoCure Limited Equity Buy 6.86% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 7.29% 6.04%
CERS Cerus Corporation Equity Sell -3.68% 6.64%
The percentage of cash held in the portfolio is: 89.53%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 6.87% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.14% 3.45%
CERS Cerus Corporation Sell -3.87% 2.37%
The percentage of cash held in the portfolio is: 89.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TVTX Travere Therapeutics, Inc. Buy 9.65% 40.42%
NVCR NovoCure Limited Buy 7.13% 2.88%
MYGN Myriad Genetics, Inc. Buy 7.09% 2.3%
CERS Cerus Corporation Sell -3.9% 1.9%
The percentage of cash held in the portfolio is: 80.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All 5.41%
ESPR Sell All 4.37%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 9.47% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -4.92%
TVTX Travere Therapeutics, Inc. Buy 9.01% 27.5%
NVCR NovoCure Limited Buy 6.8% -4.54%
MYGN Myriad Genetics, Inc. Buy 6.94% -2.56%
CERS Cerus Corporation Sell -3.97% 2.84%
The percentage of cash held in the portfolio is: 63.02%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
LMAT Buy All 2.57%
AVXL Buy All 12.76%
PODD Sell All 11.4%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.63% 10.8%
MGNX MacroGenics, Inc. Buy 9.28% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.65% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.42% 33.75%
NVCR NovoCure Limited Buy 6.65% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.11% 0.26%
LMAT LeMaitre Vascular, Inc. Sell -3.69% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.24% 14.88%
VREX Varex Imaging Corporation Sell -3.95% 2.99%
CERS Cerus Corporation Sell -3.96% 2.84%
The percentage of cash held in the portfolio is: 64.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 6.89%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.36% 7.2%
MGNX MacroGenics, Inc. Buy 9.04% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.54% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.48% 33.96%
NVCR NovoCure Limited Buy 6.56% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.17% 0.63%
STAA STAAR Surgical Company Sell -3.6% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.71% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.35% 12.41%
VREX Varex Imaging Corporation Sell -3.58% 12.56%
CERS Cerus Corporation Sell -3.92% 4.27%
The percentage of cash held in the portfolio is: 68.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
SGMO Buy All -22.22%
ALDX Sell All -6.49%
AADI Sell All 3.43%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.65% 4.57%
PODD Insulet Corporation Buy 9.33% 5.05%
MGNX MacroGenics, Inc. Buy 8.66% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.43% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.23% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.42% -3.01%
NVCR NovoCure Limited Buy 6.78% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.25% 0%
STAA STAAR Surgical Company Sell -3.79% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.84% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.4% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.55% -17.04%
BGNE BeiGene, Ltd. Sell -3.28% 0.24%
VREX Varex Imaging Corporation Sell -4.11% 1.28%
CERS Cerus Corporation Sell -3.99% 4.27%
SGMO Sangamo Therapeutics, Inc. Sell -3.04% 0%
The percentage of cash held in the portfolio is: 67.25%
New Assets Added
  • SGMO
  • MYGN
Assets Removed
Asset Action Perf %
CDMO Buy All 16.54%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.51% 2.86%
PODD Insulet Corporation Buy 9.35% 5.72%
MGNX MacroGenics, Inc. Buy 8.96% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.75% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.41% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 7.61% 0%
NVCR NovoCure Limited Buy 7.22% 0%
CDMO Avid Bioservices, Inc. Sell -3.34% 14.93%
STAA STAAR Surgical Company Sell -3.79% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.66% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.01% -3.7%
BGNE BeiGene, Ltd. Sell -3.26% 0.1%
VREX Varex Imaging Corporation Sell -4.24% -2.31%
CERS Cerus Corporation Sell -4.09% 1.42%
The percentage of cash held in the portfolio is: 74.41%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
CARA Sell All -6.41%
AGEN Sell All -8.59%
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 5.62% -6.12%
AGEN Agenus Inc. Buy 5.31% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.49% 2.86%
PODD Insulet Corporation Buy 9.17% 3.96%
MGNX MacroGenics, Inc. Buy 8.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.23% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.48% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 7.59% 0%
CDMO Avid Bioservices, Inc. Sell -3.42% 12.67%
STAA STAAR Surgical Company Sell -3.81% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.69% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.77% 2.22%
BGNE BeiGene, Ltd. Sell -3.21% 1.63%
VREX Varex Imaging Corporation Sell -4.13% 0%
CERS Cerus Corporation Sell -4.13% 0%
The percentage of cash held in the portfolio is: 70.33%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
APLS Sell All -5.21%
ORGO Sell All -4.59%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.79% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.8% -3.5%
AGEN Agenus Inc. Buy 5.43% -9.51%
CERS Cerus Corporation Buy 5.82% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.29% -0.57%
PODD Insulet Corporation Buy 8.94% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.92% -10.38%
MGNX MacroGenics, Inc. Buy 8.7% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.31% 0%
TVTX Travere Therapeutics, Inc. Buy 7.16% 0%
CDMO Avid Bioservices, Inc. Sell -3.62% 8.03%
STAA STAAR Surgical Company Sell -3.92% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.8% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.59% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.84% 0.74%
BGNE BeiGene, Ltd. Sell -3.21% 1.84%
The percentage of cash held in the portfolio is: 44.96%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.92% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.11% 4.96%
AGEN Agenus Inc. Buy 5.48% -5.85%
CERS Cerus Corporation Buy 5.82% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.34% 3.43%
NEOG Neogen Corporation Buy 6.92% 0.35%
PODD Insulet Corporation Buy 8.5% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.47% -1.15%
MGNX MacroGenics, Inc. Buy 9.02% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.02% 0%
CDMO Avid Bioservices, Inc. Sell -3.8% 0.38%
STAA STAAR Surgical Company Sell -3.89% -2.22%
PINC Premier, Inc. Sell -3.92% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% -2.38%
VERU Veru Inc. Sell -3.79% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.8% -1.48%
BGNE BeiGene, Ltd. Sell -3.17% 0%
The percentage of cash held in the portfolio is: 47.08%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.58% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.04% 3.79%
AGEN Agenus Inc. Buy 5.44% -6.58%
CERS Cerus Corporation Buy 5.78% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.89% -4%
NEOG Neogen Corporation Buy 6.75% -2.15%
PODD Insulet Corporation Buy 8.57% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.57% 0%
CDMO Avid Bioservices, Inc. Sell -3.68% 3.4%
STAA STAAR Surgical Company Sell -3.75% 1.42%
PINC Premier, Inc. Sell -3.82% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.75% 0%
AVXL Anavex Life Sciences Corp. Sell -3.75% 0%
VERU Veru Inc. Sell -3.75% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.98% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.02% 4.66%
AGEN Agenus Inc. Buy 5.92% 2.93%
CERS Cerus Corporation Buy 5.91% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.82% -4%
NEOG Neogen Corporation Buy 6.82% 0%
CDMO Avid Bioservices, Inc. Sell -3.66% 2.74%
STAA STAAR Surgical Company Sell -3.76% 0%
PINC Premier, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 63.38%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.09% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.14% 7.87%
AGEN Agenus Inc. Buy 6.11% 7.31%
CERS Cerus Corporation Buy 6% 0%
AADI Aadi Bioscience, Inc. Buy 6% 0%
CDMO Avid Bioservices, Inc. Sell -3.65% 2.08%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.71% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0.64%
ORGO Organogenesis Holdings Inc. Buy 5.93% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.81% 1.46%
AGEN Agenus Inc. Buy 6.07% 6.03%
CDMO Avid Bioservices, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 74.46%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.51% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -1.79%
ORGO Organogenesis Holdings Inc. Buy 5.63% -2.83%
CARA Cara Therapeutics, Inc. Buy 5.8% 0%
AGEN Agenus Inc. Buy 5.8% 0%
The percentage of cash held in the portfolio is: 71.57%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.76% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0%
ORGO Organogenesis Holdings Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 82.71%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-14 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All 22.42%
EGRX Buy All 15.82%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.55% 28.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.06% 13.71%
The percentage of cash held in the portfolio is: 105.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -4.91%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.2% -2.95%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.68% 24.66%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.11% 12.45%
The percentage of cash held in the portfolio is: 99.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPRX Buy All -6.15%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 5.88% -7.66%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.48% 30.04%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.18% 10.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.62% 5.86%
The percentage of cash held in the portfolio is: 103.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Buy All -20.7%
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.17% -1.96%
RMD ResMed Inc. Buy 7.81% 7.5%
INGN Inogen, Inc. Sell -3.25% 6.97%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.67% 23.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.39% 2.95%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.62% 4.47%
The percentage of cash held in the portfolio is: 98.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.38% -1.57%
HQY HealthEquity, Inc. Buy 6.23% -3.84%
SAVA Cassava Sciences, Inc. Buy 10.2% 57.44%
SAGE Sage Therapeutics, Inc. Buy 5.75% -11.19%
HCSG Healthcare Services Group, Inc. Buy 5.93% -3.72%
RMD ResMed Inc. Buy 7.71% 3.13%
INGN Inogen, Inc. Sell -3.57% 0.87%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.26% 9.42%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.63% -0.84%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.83% 1.8%
The percentage of cash held in the portfolio is: 72.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Buy All -1.17%
RARE Buy All -3.2%
NKTR Buy All 5.93%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.7% 3.34%
HQY HealthEquity, Inc. Buy 6.28% -3.09%
SAVA Cassava Sciences, Inc. Buy 9.66% 48.93%
SAGE Sage Therapeutics, Inc. Buy 6.46% -0.36%
HCSG Healthcare Services Group, Inc. Buy 6.09% -1.12%
RMD ResMed Inc. Buy 7.67% 2.5%
PODD Insulet Corporation Sell -3.69% 0.31%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.89% -5.24%
NKTR Nektar Therapeutics Sell -3.67% 0.74%
INGN Inogen, Inc. Sell -3.63% -0.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.64% -0.9%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.66% -1.69%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.91% 0%
The percentage of cash held in the portfolio is: 83.22%
New Assets Added
  • CPRX
Assets Removed
Asset Action Perf %
SMTI Buy All -6.87%
RCM Sell All -1.15%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.5% -1%
CYH Community Health Systems, Inc. Buy 6.72% 1.38%
HQY HealthEquity, Inc. Buy 6.42% -3.16%
SAVA Cassava Sciences, Inc. Buy 7.8% 17.76%
SAGE Sage Therapeutics, Inc. Buy 6.51% -1.73%
HCSG Healthcare Services Group, Inc. Buy 6.27% -0.43%
RMD ResMed Inc. Buy 7.65% 0%
PODD Insulet Corporation Sell -3.75% 0.6%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.95% -4.51%
NKTR Nektar Therapeutics Sell -3.89% -2.96%
SMTI Sanara MedTech Inc. Sell -3.68% 0%
INGN Inogen, Inc. Sell -3.68% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.68% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.68% 0%
The percentage of cash held in the portfolio is: 78.46%
New Assets Added
  • SMTI
  • INGN
  • LXRX
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.32% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 7.2% -4.26%
SMTI Sanara MedTech Inc. Buy 6.19% -5.45%
CYH Community Health Systems, Inc. Buy 6.66% 1.77%
HQY HealthEquity, Inc. Buy 6.44% -1.69%
SAVA Cassava Sciences, Inc. Buy 7.91% 20.78%
SAGE Sage Therapeutics, Inc. Buy 6.44% -1.64%
HCSG Healthcare Services Group, Inc. Buy 6.22% 0%
PODD Insulet Corporation Sell -3.67% 1.61%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.95% -5.75%
NKTR Nektar Therapeutics Sell -3.76% -0.74%
The percentage of cash held in the portfolio is: 58%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
FATE Sell All 39.07%
VERU Sell All -1.22%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 7.27% 39.85%
VERU Veru Inc. Buy 5.19% -0.17%
RCM R1 RCM Inc. Buy 6.46% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 8.21% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 7.62% 1.6%
SMTI Sanara MedTech Inc. Buy 6.53% 0%
CYH Community Health Systems, Inc. Buy 6.53% 0%
HQY HealthEquity, Inc. Buy 6.53% 0%
SAVA Cassava Sciences, Inc. Buy 6.53% 0%
SAGE Sage Therapeutics, Inc. Buy 6.53% 0%
PODD Insulet Corporation Sell -3.69% 0.85%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.91% -4.86%
NKTR Nektar Therapeutics Sell -3.81% -2.22%
RMD ResMed Inc. Sell -3.72% 0%
The percentage of cash held in the portfolio is: 47.72%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
  • SAVA
  • SAGE
Assets Removed
Asset Action Perf %
WAT Buy All -5.03%
MASI Sell All -2.65%
BKD Sell All 8.27%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 1.69% -1.95%
BKD Brookdale Senior Living Inc. Buy 1.82% 5.96%
FATE Fate Therapeutics, Inc. Buy 7.2% 38.82%
VERU Veru Inc. Buy 5.18% -0.17%
RCM R1 RCM Inc. Buy 6.41% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 8.45% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 7.49% 0%
PODD Insulet Corporation Sell -3.64% 2.09%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.92% -5.33%
NKTR Nektar Therapeutics Sell -3.77% -1.48%
WAT Waters Corporation Sell -3.78% -2.5%
The percentage of cash held in the portfolio is: 76.86%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
ANGO Sell All 22.51%
SGRY Sell All 20.35%
AVNS Sell All 8.22%
CUTR Sell All -5.41%
RGNX Sell All 13.22%
SUPN Sell All 7.69%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 7.21% 19.58%
SGRY Surgery Partners, Inc. Buy 7% 16.16%
AVNS Avanos Medical, Inc. Buy 6.43% 6.7%
CUTR Cutera, Inc. Buy 5.86% -2.7%
RGNX REGENXBIO Inc. Buy 6.47% 7.32%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.44% 6.84%
MASI Masimo Corporation Buy 1.7% -2.4%
BKD Brookdale Senior Living Inc. Buy 1.85% 6.23%
FATE Fate Therapeutics, Inc. Buy 6.98% 33.16%
VERU Veru Inc. Buy 5.23% -0.17%
RCM R1 RCM Inc. Buy 6.59% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 8.61% 0%
PODD Insulet Corporation Sell -3.74% 0.3%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.96% -5.45%
NKTR Nektar Therapeutics Sell -3.92% -4.44%
WAT Waters Corporation Sell -3.75% -0.86%
The percentage of cash held in the portfolio is: 45.03%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
PDSB Sell All 6.96%
OPK Sell All 7.58%
SAGE Sell All -11.55%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.25% 9.94%
OPK OPKO Health, Inc. Buy 7.45% 12.88%
ANGO AngioDynamics, Inc. Buy 7.06% 17.13%
SGRY Surgery Partners, Inc. Buy 6.86% 13.7%
AVNS Avanos Medical, Inc. Buy 6.26% 3.82%
CUTR Cutera, Inc. Buy 6.48% 7.43%
RGNX REGENXBIO Inc. Buy 5.97% -1.02%
SAGE Sage Therapeutics, Inc. Buy 6.32% 4.73%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.4% 6.18%
MASI Masimo Corporation Buy 1.66% -4.64%
BKD Brookdale Senior Living Inc. Buy 1.8% 3.66%
FATE Fate Therapeutics, Inc. Buy 5.76% 9.77%
VERU Veru Inc. Buy 4.96% -5.42%
RCM R1 RCM Inc. Buy 6.66% 2%
PODD Insulet Corporation Sell -3.76% -0.04%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.74% 0.54%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
WAT Waters Corporation Sell -3.73% 0%
The percentage of cash held in the portfolio is: 34.19%
New Assets Added
  • WAT
Assets Removed
Asset Action Perf %
TDOC Sell All -2.99%
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.22% 9.66%
ALT Altimmune, Inc. Buy 5.76% -12.43%
OPK OPKO Health, Inc. Buy 7.58% 15.15%
ANGO AngioDynamics, Inc. Buy 6.82% 13.38%
TDOC Teladoc Health, Inc. Buy 5.98% -0.64%
SGRY Surgery Partners, Inc. Buy 6.85% 13.89%
AVNS Avanos Medical, Inc. Buy 6.37% 5.95%
CUTR Cutera, Inc. Buy 6.3% 4.73%
RGNX REGENXBIO Inc. Buy 6.08% 1.1%
SAGE Sage Therapeutics, Inc. Buy 6.24% 3.71%
SUPN Supernus Pharmaceuticals, Inc. Buy 6.15% 2.14%
MASI Masimo Corporation Buy 1.67% -4.06%
BKD Brookdale Senior Living Inc. Buy 1.81% 4.07%
FATE Fate Therapeutics, Inc. Buy 5.8% 10.8%
VERU Veru Inc. Buy 5.17% -1.22%
RCM R1 RCM Inc. Buy 6.42% -1.46%
PODD Insulet Corporation Sell -3.75% 0%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.75% 0%
NKTR Nektar Therapeutics Sell -3.75% 0%
The percentage of cash held in the portfolio is: 19.03%
New Assets Added
  • PODD
  • RARE
  • NKTR
Assets Removed
Asset Action Perf %
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.26% 13.92%
ALT Altimmune, Inc. Buy 6.38% 0.13%
OPK OPKO Health, Inc. Buy 6.86% 7.58%
WST West Pharmaceutical Services, Inc. Buy 5.72% -1.88%
ANGO AngioDynamics, Inc. Buy 7.04% 20.72%
TDOC Teladoc Health, Inc. Buy 6.24% 7.04%
SGRY Surgery Partners, Inc. Buy 6.74% 15.66%
AVNS Avanos Medical, Inc. Buy 6.23% 6.89%
CUTR Cutera, Inc. Buy 6.58% 12.84%
RGNX REGENXBIO Inc. Buy 6.09% 4.48%
SAGE Sage Therapeutics, Inc. Buy 6.03% 3.54%
SUPN Supernus Pharmaceuticals, Inc. Buy 5.92% 1.61%
MASI Masimo Corporation Buy 1.64% -2.67%
BKD Brookdale Senior Living Inc. Buy 1.76% 4.74%
FATE Fate Therapeutics, Inc. Buy 5.81% 14.65%
VERU Veru Inc. Buy 5.38% 6.14%
RCM R1 RCM Inc. Buy 6.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings